3-(2-((2,5-Disulfophenyl)diazenyl)-4-formyl-5-hydroxy-6-methylpyridin-3-yl)propanoic acid

ID: ALA2376126

Chembl Id: CHEMBL2376126

PubChem CID: 136088910

Max Phase: Preclinical

Molecular Formula: C16H15N3O10S2

Molecular Weight: 473.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(/N=N/c2cc(S(=O)(=O)O)ccc2S(=O)(=O)O)c(CCC(=O)O)c(C=O)c1O

Standard InChI:  InChI=1S/C16H15N3O10S2/c1-8-15(23)11(7-20)10(3-5-14(21)22)16(17-8)19-18-12-6-9(30(24,25)26)2-4-13(12)31(27,28)29/h2,4,6-7,23H,3,5H2,1H3,(H,21,22)(H,24,25,26)(H,27,28,29)/b19-18+

Standard InChI Key:  DRLAZBVZFMPCLR-VHEBQXMUSA-N

Alternative Forms

  1. Parent:

    ALA2376126

    ---

Associated Targets(Human)

P2RX7 Tchem P2X purinoceptor 7 (5534 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2RX3 Tclin P2X purinoceptor 3 (1991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2rx1 P2X purinoceptor 1 (68 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 473.44Molecular Weight (Monoisotopic): 473.0199AlogP: 1.83#Rotatable Bonds: 8
Polar Surface Area: 220.95Molecular Species: ACIDHBA: 10HBD: 4
#RO5 Violations: HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: -3.22CX Basic pKa: CX LogP: -2.30CX LogD: -6.59
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.25Np Likeness Score: -0.25

References

1. Jung KY, Cho JH, Lee JS, Kim HJ, Kim YC..  (2013)  Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.,  21  (9): [PMID:23510563] [10.1016/j.bmc.2013.01.073]

Source